Lessons from cholesterol-lowering trials
- 1 June 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (6) , 28S-32S
- https://doi.org/10.1016/s0002-9343(98)00185-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of Fluvastatin on Coronary Atherosclerosis in Patients With Mild to Moderate Cholesterol Elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])The American Journal of Cardiology, 1997
- The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass GraftsNew England Journal of Medicine, 1997
- ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1996
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Heart Attacks: Gone with the Century?Science, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Epidemiology of coronary heart disease: The Framingham studyThe American Journal of Medicine, 1984
- Multiple Risk Factor Intervention TrialJAMA, 1982
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975